Illidge T, Wilson W, Paterson J, Bates A, Cheadle E, Collins G, Cowan R, El-Mehidi N, Gallop-Evans E, James E, Adedayo T, Osborne W, O’Rourke N, Pawade J, Scarisbrick J, Ward J, Whittaker S, Morris S. Final results of UK NCRI phase II trial of pembrolizumab and radiotherapy in cutaneous T cell lymphoma. Haematologica; https://doi.org/10.3324/haematol.2025.288878 [Early view].